Freeline is a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases.
For more details on financing and valuation for Freeline Therapeutics, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
FRLN
0.4369 as of 3/24/23
To read this article and more news on Freeline Therapeutics, register or login.
